Prognostic value of 18F-FDG PET/CT parameters and histopathologic variables in head and neck cancer

Introduction: F-18-fluorodeoxyglucose positron emission tomography/computed tomography parameters such as; maximum standardized uptake values, standard metabolic tumor volume and otal lesion glycosis are important prognostic biomarkers in cancers. Objective: To investigate the prognostic value of these parameters in patients with head and neck cancers. Methods: We performed a retrospective study including 47 patients with head and neck cancer who underwent F-18-fluorodeoxyglucose positron emission tomography/computed tomography prior to treatment. Standard metabolic tumor volume, otal lesion glycosis and standardized uptake were measured for each patient. The prognostic value of quantitative F-18-fluorodeoxyglucose positron emission tomography/computed tomography parameters and clinicopathologic variables on disease free survival and overall survival were analyzed. Results: The median (range) standard metabolic tumor volume and otal lesion glycosis and standardized uptake were 7.63 cm(3) (0.6-34.3), 68.9 g (2.58-524.5 g), 13.89 (4.89-33.03 g/mL), respectively. Lymph node metastases and tumour differentiation were significant variables for disease free survival and overall survival, however, all F-18-fluorodeoxyglucose positron emission tomography/computed tomography parameters were not associated with disease- free survival and overall survival. Conclusion: Pretreatment quantities positron emission tomography parameters did not predict survival in head and neck cancer. (C) 2019 Associacao Brasileira de Otorrinolaringologia e Cirurgia Cervico-Facial. Published by Elsevier Editora Ltda.

Automated summary

This study investigated the prognostic value of F-18-fluorodeoxyglucose positron emission tomography/computed tomography parameters in head and neck cancer patients, and found that these parameters were not associated with disease-free survival and overall survival.